市場調查報告書
商品編碼
990422

生物原料的全球市場 (2020年∼2027年)

Global Biotech Ingredients Market - 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

全球生物原料市場主要促進因素,是在食品、飲料產業上生物系香料及香水的需求增加,及個人保養用品、化妝品的需求增加,以合理的價格減少碳排放的關心增加,受消費者歡迎等。另一方面,原料的可得性限制等也有可能妨礙市場成長。在各產品中,單株抗體需求近幾年急速擴大。在各地區中,歐洲各國是最大的市場,北美各國其次。

本報告提供全球生物原料的市場相關分析,市場規模趨勢預測,及各產品、各表達系統、各用途、各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球生物原料市場:分析方法、範圍

第2章 全球生物原料市場:市場定義和概要

第3章 全球生物原料市場:摘要整理

第4章 全球生物原料市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響力分析

第5章 全球生物原料市場:產業分析

  • 波特的五力分析
  • 供應鏈分析
  • 價格分析
  • 法規分析

第6章 全球生物原料市場:新型冠狀病毒感染疾病 (COVID-19)的分析

  • COVID-19對市場的影響分析
    • "COVID-19前" /過去的市場情境
    • "COVID-19中" /目前市場情境
    • "COVID-19後" /未來市場情境
  • COVID-19流行中的價格趨勢
  • 需求與供給的變動階段
  • 對感染擴大時的市場的政府的配合措施
  • 各製造公司的策略展開情形
  • 結論

第7章 全球生物原料市場:各類型

  • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各類型
    • 市場向心力指數:各類型
  • 創新的生物API (醫藥品原料藥)
    • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY)
  • 非專利、生物API/生物相似藥

第8章 全球生物原料市場:各產品

  • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各產品
    • 市場向心力指數:各產品
  • 單株抗體
  • 疫苗
  • 細胞激素
  • 融合蛋白質
  • 治療用酵素
  • 荷爾蒙、成長因素
  • 血液因子
  • 其他

第9章 全球生物原料市場:各表達系統

  • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各表達系統
    • 市場向心力指數:各表達系統
  • 微生物
  • 哺乳類細胞
  • 植物細胞
  • 酵母
  • 昆蟲細胞
  • 其他

第10章 全球生物原料市場:各用途

  • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各用途
    • 市場向心力指數:各用途
  • 食品、飲料
  • 化妝品、個人保養用品
    • 護膚用品
    • 護髮
    • 防曬用品
    • 化妝品、彩妝品
  • 其他

第11章 全球生物原料市場:各地區

  • 簡介
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各地區
    • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各產品
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各表達系統
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各用途
    • 市場規模的分析及與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東、非洲

第12章 全球生物原料市場:競爭情形

  • 競爭方案
  • 市場定位/佔有率分析
  • 企業合併、收購 (M&A)的分析

第13章 全球生物原料市場:企業簡介

  • Mibelle Group
    • 企業概要
    • 各種類的產品系列/概要
    • 近幾年趨勢
    • 財務分析:概要
  • Advanced Biotech
  • International Flavors and Fragrance (IFF)
  • Bell Flavors and Fragrances
  • Sigma-Aldrich
  • Hayashibara Co
  • Firmenich SA
  • Novozymes SA
  • Evonik Nutrition and Care
  • Symrise A.G
  • Contipro a.s
  • Givaudan SA

第14章 全球生物原料市場:重要考察

第15章 關於DataM Intelligence

目錄

Market Overview

The global biotech ingredients market size was worth US$ XX billion in 2019 and is estimated to show significant growth by reaching up to US$ XX billion by 2027, growing at a CAGR of XX% during the forecast period (2020-2027).

Biotech ingredients are the set of large and complex chemical mixtures that show structural resemblance to compounds found in organisms, animals, and botanical biological sources. Various biotechnological processes such as hybridoma technology, genetic engineering, and others are involved in manufacturing biotech ingredients.

Biotech ingredients can be exacted directly from microbes like bacteria and yeast through genetic modifications. Biotech ingredients include essential oils, oleoresins, and several other plant extracts manufactured using steam distillation, cold pressing or compression, carbon dioxide extraction, and solvent extraction as the modern techniques for extraction of biotech ingredients. These ingredients are widely used in various personal care and cosmetic items, food & beverages, and cleansing & household items. Carbonyls, alcohols, lactones, acids are a few of the types of biotech ingredients currently ruling the market.

Market Dynamics

The global biotech ingredients market is majorly driven by the increasing demand for biotech flavors and fragrance ingredients from the food and beverage sectors. The growing demand for biotech ingredients for its most prominent usage in the personal care & cosmetic sectors to generate lower carbon footprint at an affordable rate is further expected to trigger the market of biotech ingredients in the coming tenure.

Increasing demand for biotech flavors and fragrance ingredients from food and beverage sectors

With growing awareness among the population towards adopting natural products and increasing knowledge about synthetic ingredients' side effects has shifted consumers' preference towards naturally derived products. Both flavors and fragrances can be derived either from a natural source or can be made synthetically.

However, due to limited availability of raw materials and unpredictable weather conditions during crop season, a significant manufacturer shift has adopted a more sustainable production approach. It creates opportunities for various flavors and fragrance industries to develop new and sustainable production methods for these ingredients, which can be labeled as natural and meet consumer demand and expectations. Thus this sudden shift boosts the biotech ingredients market and is expected to maintain the momentum in the coming years.

For instance, in March 2020, Evolva enters a new agreement with International Flavors & Fragrances, a leading player and creator of taste, scents, and nutrition for consumers' products. The agreement was made to expand further and develop the commercialization of vanillin.

The growing demand for biotech ingredients for its most prominent usage in the personal care & cosmetic sectors generates a lower carbon footprint at an affordable rate

As per various statistical reports, cosmetics and the cosmetics market are estimated to register an annual growth of 25% by touching USD 20 billion by 2025. Solely Indian cosmeceutical and cosmetics industry holds around USD 6.5 billion from a global market of USD 274 billion. The significant growth in the cosmetics industry is due to increasing consumer shift towards organic and natural beauty products.

It also creates opportunities for cosmetic product manufacturers to incorporate these ingredients in their products to fulfill the consumer's demand. In return, this leads to create immense opportunities for the biotech sector and biotech-based active ingredients to increase in the recent cosmetics market. The production of these biotech ingredients used in cosmetic products is often cleaner, more sustainable, and more efficacious beauty ingredients as compared to those extracted from a petrochemical source.

For instance, in October 2019, Mibelle launched an anti-aging remedy- IceAwake, for sleep-deprived consumers. The product is a biotech ingredient made available by glacial melt. Bacteria present in glacier ice layer help Mibelle biochemistry produce 'IceAwake,' an ingredient that helps rejuvenate skin caused by prolonged periods of inadequate sleep.

Limited availability of raw materials owing to the requirement of ambient conditions for the growth of microorganisms coupled with stringent regulatory norms imparted by government bodies

Biotechnological processes have significantly increased research sectors' growth, and rapid growth in various end-users has been seen in the past two decades. However, many biotechnological processes may carry more risks than any other scientific field, such as microorganisms used to produce different biotech ingredients are very tiny and hard to handle sometimes, which creates unavoidable dangers.

Also, the raw materials and conditions required for the production of biotech ingredients are cost-effective, and the maintenance of such ambient conditions becomes unfeasible, affecting the volume and quality of end-products. Many projects are still on hold due to stringent government regulatory norms, leading to an impact on market's growth. Thus, the limitation mentioned above of a biotechnological process is directly responsible for hurdling the biotech ingredient market's growth in recent times.

COVID-19 Impact Analysis

The global biotech ingredient has shown a slight decline due to the COVID-19 pandemic, as several manufacturing plants were shut down for several months. Further several countries have restricted production activities during the covid-19 pandemic. The major lockdown due to the COVID-19 outbreak leads to suddenly dropping down consumers' interest towards purchasing any goods, and halt in transportation sectors has severely hampered biotech ingredient market business due to disruption in the product's supply chain management.

The majority of businesses is shut down, and operations across several end-users of biotech ingredient products such as food & beverages industries and cosmetic industries are also compromised, thus dropping the product's global demand in 2020. Also, due to the on-going pandemic majority of the research projects are shifted towards identifying the coronavirus behavior and finding out the possible cure for the illness, leading to halting the previously going project expected to hamper the future growth of biotech ingredients.

Segment Analysis

The global biotech ingredient market is segmented based on type, product, expression system, application and region.

Increasing cancer-positive patients and growing demand to treat oncology patients has uplifted the market of monoclonal antibodies in the recent times

In terms of product, the global biotech ingredient market is bifurcated into vaccines, monoclonal antibodies, cytokines, fusion proteins, therapeutic enzymes, hormones and growth factors, blood factors, and others. Out of the mentioned list, the monoclonal antibody segment is growing at the largest rate since the past recent years. The market is expected to maintain its dominance in the forecast period, owing to the high adoption of monoclonal antibodies in cancer and infectious treatment.

The growing use of monoclonal antibodies for cancer therapy has significantly contributed to tumor immunology and advanced the on-going procedure for treating oncology patients. As per WHO 2018, cancer is the second leading cause of death worldwide, and till 2018 it is responsible for taking 9.6 million lives. Nearly 70% of deaths due to cancer occurs in low and middle-income countries.

Currently, the most common types of cancers are- lung cancer (2.09 million), breast cancer (2.09 million), colorectal cancer (1.80 million), prostate (1.28 million), skin cancer (non-melanoma) (1.04 million), and stomach cancer (1.03 million). The rapidly growing cancer patients are directly responsible for creating monoclonal antibodies to treat cancer. These antibodies can enhance or mimic the immune system and attack the cancer cells present in the affected patient. Monoclonal antibodies are also designed to function in a variety of ways, particularly in a drug form. These drugs are helping the immune system fight against cancerous cells in different ways.

Geographical Analysis

Increasing demand for these ingredients in the cosmetics and fragrances sector and growing on-going developments in the biotechnology sectors has improved the market share of the European region

Europe holds the highest 2019 market of biotech ingredients due to the increasing demand for these ingredients in the cosmetics and fragrances sector. Growing on-going developments in the biotechnology sectors and rising government investments on the projected have shown a severe growth impact on the biotech ingredient market in recent times. The increasing production capacity of bio-based chemicals and growing key players' adoption of biotech ingredients has uplifted Europe's market share.

On the other side, North America is in the second position for the biotech ingredient market due to the tremendous growth of biotech ingredients R &D over the past few years. Growing government regulations favoring biotech ingredients is another factor adding to the region's market.

Competitive Landscape

The biotech ingredient market is highly competitive with the presence of local as well as global companies. Some of the key players contributing to the market's growth include Advanced Biotech, International Flavors and Fragrance (IFF), Bell Flavors and Fragrances, Sigma-Aldrich, Hayashibara Co, Firmenich SA, Novozymes SA, Evonik Nutrition and Care, Symrise A.G, Contipro a.s, Givaudan SA, Mibelle Group and among others.

The major players adopt several growth strategies such as product launches, acquisitions, and collaborations, contributing to the biotech ingredient market's growth globally. However, the key players are following collaboration and acquisition as the growth strategy.

  • For instance, in June 2019, Symrise announced its acquisition of an Italian biotech company Cutech in Padua. The company is generating revenue by offering unique pre-clinical screening services for cosmetic ingredients and finished formulations
  • In March 2020, Evolva entered a new agreement with International Flavors & Fragrances, a leading player and creator of taste, scents, and nutrition for consumers' products. The deal was made to expand further and develop the commercialization of vanillin

Mibelle Group

Overview: The company is the third-ranked own-brand manufacturer in the European market. The company develops, produces, and markets its brands and own retail brands in Personal Care & beauty, homecare, and nutrition. The company employed nearly 12,50 people over six sits in Switzerland, UK and holds a turnover of around 650 million Swiss francs.

Product Portfolio: The company has a product portfolio of biotech ingredient includes:

  • NanoMax: A double nanoemulsion formed by combing Q10 with vitamin C & E. Coenzyme Q10 is one of the strongest antioxidants capable of activating cell metabolism. The above combination can synergistically fight against oxidants, provide a high antioxidant protection level to the skin, and is a perfect daily care product

Key Development:

  • In October 2019, Mibelle launched an anti-aging remedy- IceAwake, for sleep-deprived consumers. The product is a biotech ingredient made available by glacial melt. With the help of the bacteria present in the glacier ice layer, Mibelle biochemistry produced IceAwake- an ingredient that helps rejuvenate skin caused by prolonged periods of inadequate sleep

Why Purchase the Report?

  • Visualize the biotech ingredient market segmentation by type, product, expression system, application and highlight key commercial assets and players.
  • Identify commercial opportunities in the biotech ingredient market by analyzing trends and co-development deals.
  • Excel data sheet with thousands of data points of biotech ingredient market-level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key product of all major market players

The global biotech ingredient market report would provide access to an approx: 75 market data table, 72 figures, and 244 pages.

Target Audience 2022

  • Service Providers/ Buyers
  • Industry Investors/Investment Bankers
  • Education & Research Institutes
  • Research Professionals
  • Emerging Companies
  • Manufacturers

Table of Contents

1. Global Biotech Ingredients Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Biotech Ingredients Market - Market Definition and Overview

3. Global Biotech Ingredients Market - Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Product
  • 3.3. Market Snippet by Expression System
  • 3.4. Market Snippet by Application
  • 3.5. Market Snippet by Region

4. Global Biotech Ingredients Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing demand for biotech flavors and fragrance ingredients from food and beverage sectors
      • 4.1.1.2. The growing demand for biotech ingredients for its most prominent usage in the personal care & cosmetic sectors generates a lower carbon footprint at an affordable rate
      • 4.1.1.3. XX
    • 4.1.2. Restraints:
      • 4.1.2.1. Limited availability of raw materials owing to the requirement of ambient conditions for the growth of microorganisms coupled with stringent regulatory norms imparted by government bodies
      • 4.1.2.2. XX
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Biotech Ingredients Market - Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. Global Biotech Ingredients Market - COVID-19 Analysis

  • 6.1. Analysis of COVID-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. Global Biotech Ingredients Market - By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. Innovative Biotech APIs*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Generic biotech APIs/ Biosimilar

8. Global Biotech Ingredients Market - By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Monoclonal Antibodies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Vaccines
  • 8.4. Cytokines
  • 8.5. Fusion Proteins
  • 8.6. Therapeutic Enzymes
  • 8.7. Hormones and Growth Factors
  • 8.8. Blood Factors
  • 8.9. Others

9. Global Biotech Ingredients Market - By Expression System

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression system
    • 9.1.2. Market Attractiveness Index, By Expression system
  • 9.2. Microbial *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Mammalian
  • 9.4. Plant
  • 9.5. Yeast
  • 9.6. Insect
  • 9.7. Others

10. Global Biotech Ingredients Market - By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Food & Beverages*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Cosmetics & Personal Care
    • 10.3.1. Skin Care
    • 10.3.2. Hair Care
    • 10.3.3. Sun Care
    • 10.3.4. Makeup & Color Cosmetics
  • 10.4. Others

11. Global Biotech Ingredients Market - By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Russia
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Expression System
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Global Biotech Ingredients Market - Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Global Biotech Ingredients Market- Company Profiles

  • 13.1. Mibelle Group*
    • 13.1.1. Company Overview
    • 13.1.2. Type Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Advanced Biotech
  • 13.3. International Flavors and Fragrance (IFF)
  • 13.4. Bell Flavors and Fragrances
  • 13.5. Sigma-Aldrich
  • 13.6. Hayashibara Co
  • 13.7. Firmenich SA
  • 13.8. Novozymes SA
  • 13.9. Evonik Nutrition and Care
  • 13.10. Symrise A.G
  • 13.11. Contipro a.s
  • 13.12. Givaudan SA

LIST NOT EXHAUSTIVE

14. Global Biotech Ingredients - Premium Insights

15. Global Biotech Ingredients - DataM

  • 15.1. Appendix
  • 15.2. About Us and Services
  • 15.3. Contact Us